ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 756738 DIGOXIN 0.0490935610249067 0.47039724
NSC 97960 Null 0.0490935610249067 0.35898005
NSC 1011 P-[[.ALPHA.-(8-HYDROXY-7-QUINOLYL)BENZYL]AMINO]BENZOIC ACID 0.049093561024907 0.44477181
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 1.69382348758652e-006 0.76669077
NSC 618939 Camptothecin Derivative 1.96611114629698e-007 0.86541217
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 1.96611114629698e-007 0.76128812
NSC 639174 Camptothecin Derivative 2.16417361041569e-005 0.81659178
NSC 697189 Null 2.16417361041569e-005 0.52222154
NSC 705437 Null 2.16417361041569e-005 0.68289381
NSC 740564 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 2.16417361041569e-005 0.67054864
Total:90  Current:87    [First] [Prev] [Next] [Last]